Oxford Pharmaceitical Sciences Limited Company Profile

22:33 EDT 21st March 2018 | BioPortfolio

s a professional clinical research organisation, OPS is committed to a culture of quality and excellence and applies best practice throughout the business.

Working with major blue-chip clients, the company attracts and retains only the best people. Its commitment to career development enables OPS to employ a stable and experienced workforce delivering consistency, quality and an unparalleled level of service.

OPS forms a genuine partnership with clients, with staff becoming an integral part of the client's business. By combining its resources and expertise with those of the client, OPS achieves both critical development objectives and the successful completion of clinical trial programmes - on time, every time.

The organisation encourages pragmatic teamwork, proactive and responsive communication, coupled with a friendly, helpful and willing attitude. By employing a consultative approach to clinical research, OPS customises solutions to clients' specific needs, ensuring a fast, accurate and cost effective service.

Those services include:

Resource solutions

Biometric consultancy

Clinical research

Expanding rapidly, OPS is now a leading force in the clinical research arena, with in-house biometricians and field-based consultants engaging in ever more challenging research programmes for a growing portfolio of internationally-based pharmaceutical clients.


Unit 1A, Kingston Business Park
Kingston Bagpuize
OX13 5FE
United Kingdom


Phone: +44 (0) 1865 823823
Fax: +44 (0) 1865 821868

News Articles [805 Associated News Articles listed on BioPortfolio]

Oxford mothers-to-be learn about gestational diabetes research

Oxford researchers have attended two events in Oxford to let pregnant women know how to have a healthy pregnancy and to ask them to get involved in giving their views on future research. The researche...

Oxford Centre for Haematology launched

The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxfor...

Oxford Keeps Growing as a Hotspot for Cancer Vaccines with New Fundraising

Oxford Vacmedix has secured $12.5M (€10M) to start its first clinical trials, joining other Oxford-based biotechs in the cancer vaccine field such as Vaccitech and SpyBiotech. Oxford Vacmedix has s...

Oxford and Berlin create partnership to open up new research initiatives

The partnership will build on existing research links involving the five universities and create an environment for forging new projects in medicine, the sciences, humanities and social sciences among...

AI could save NHS billions in scan costs, says life sciences tsar

Using artificial intelligence (AI) to diagnose scans for heart disease and lung cancer could save the NHS billions of pounds, according to life sciences tsar, Sir John Bell. The BBC reported that res...

Cells rank genes by importance to protect them, according to new research

(University of Oxford) Researchers at the University of Oxford have discovered that a cellular mechanism preferentially protects plant genes from the damaging effects of mutation.A new study, carried ...

Oxford Immunotec: Oxford Immunotec and QIAGEN N.V. Settle Patent Infringement Lawsuit

Oxford Immunotec and QIAGEN N.V. Settle Patent Infringement Lawsuit Agreement includes payment of $27.5 million to Oxford, royalty-free license to QIAGEN and dismissal of all pending litigation OXF...

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Clinical Trials [249 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [1206 Associated Companies listed on BioPortfolio]

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford Lasers, Inc.

Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards th...

Oxford Pharmaceitical Sciences Limited

s a professional clinical research organisation, OPS is committed to a culture of quality and excellence and applies best practice throughout the business.Working with major blue-chip clients, the com...

More Information about "Oxford Pharmaceitical Sciences Limited" on BioPortfolio

We have published hundreds of Oxford Pharmaceitical Sciences Limited news stories on BioPortfolio along with dozens of Oxford Pharmaceitical Sciences Limited Clinical Trials and PubMed Articles about Oxford Pharmaceitical Sciences Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Pharmaceitical Sciences Limited Companies in our database. You can also find out about relevant Oxford Pharmaceitical Sciences Limited Drugs and Medications on this site too.

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record